The Middle East and Africa kyphoplasty market was estimated at $4.1M in 2016 across the five markets (Egypt, Israel, Saudi Arabia, South Africa, and United Arab Emirates [UAE]) covered in this report. By the end of the forecast period in 2023, it is estimated that market will grow to approximately $8.2M at a Compound Annual Growth Rate (CAGR) of 10.4%.
Market for VCF repair products, including kyphoplasty balloons and kits, is a highly consolidated market. Together, three orthopedic conglomerates-DePuy Synthes, Medtronic, and Stryker-dominated the global market in 2016. These companies hold well-established orthopedic portfolios and enjoy wide-ranging distribution networks, which allow them to effectively cross-sell their VCF products. Several minor players also operate in regional markets, and domestic manufacturers of cheap copycat products are a threat in developing countries.
Key drivers of the kyphoplasty market in the forecast period are:
- The rising prevalence of osteoporosis and osteopenia due to the increasing aging population.
- The increasing preference for minimally invasive and outpatient procedures.
Key Topics Covered:
1. About the Authors
2. Table of Contents
3. Executive Summary
5. Market Outlook
6. Market Insights
7. Competitive Assessment
- DePuy Synthes (Johnson & Johnson)
- Globus Medical
Read more here.